Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Type of hormone replacement therapy and risk of venous thromboembolism.

× No keyword cloud information.

14 in total

Review 1. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.

Authors: Heidi D Nelson
Journal: JAMA Date: 2004-04-07 Impact factor: 56.272

2. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.

Authors: Nicholas L Smith; Susan R Heckbert; Rozenn N Lemaitre; Alexander P Reiner; Thomas Lumley; Frits R Rosendaal; Bruce M Psaty
Journal: Arterioscler Thromb Vasc Biol Date: 2006-09-14 Impact factor: 8.311

3. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.

Authors:
Journal: Menopause Date: 2007 Mar-Apr Impact factor: 2.953

4. Review of an article: Canonico M, Plu-Bureau G, Lowe G, Scarabin P. (2008). Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. British Medical Journal 10(336):1227-1231.

Authors: Janice D Nunnelee
Journal: J Vasc Nurs Date: 2009-03

5. Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins.

Authors: Terry White; Begüm Ozel; John K Jain; Frank Z Stanczyk
Journal: Contraception Date: 2006-06-27 Impact factor: 3.375

6. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

Authors: Marianne Canonico; Emmanuel Oger; Geneviève Plu-Bureau; Jacqueline Conard; Guy Meyer; Hervé Lévesque; Nathalie Trillot; Marie-Thérèse Barrellier; Denis Wahl; Joseph Emmerich; Pierre-Yves Scarabin
Journal: Circulation Date: 2007-02-20 Impact factor: 29.690

7. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.

Authors: J Alexander Cole; Heather Norman; Michael Doherty; Alexander M Walker
Journal: Obstet Gynecol Date: 2007-02 Impact factor: 7.661

8. A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study.

Authors: S C Clarke; J Kelleher; H Lloyd-Jones; M Slack; P M Schofiel
Journal: BJOG Date: 2002-09 Impact factor: 6.531

9. Breast cancer and hormone-replacement therapy in the Million Women Study.

Authors: Valerie Beral
Journal: Lancet Date: 2003-08-09 Impact factor: 79.321

10. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.

Authors: Gerardo Heiss; Robert Wallace; Garnet L Anderson; Aaron Aragaki; Shirley A A Beresford; Robert Brzyski; Rowan T Chlebowski; Margery Gass; Andrea LaCroix; JoAnn E Manson; Ross L Prentice; Jacques Rossouw; Marcia L Stefanick
Journal: JAMA Date: 2008-03-05 Impact factor: 56.272

2 in total

1. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study.

Authors: Julia Hippisley-Cox; Carol Coupland
Journal: BMJ Date: 2011-08-16

2. Involvement of Cisgender and Transgender Individuals in Studies on the Impact of Hormonal Therapy on COVID-19.

Authors: Robert J Wozniak; Douglas F Nixon; Jez L Marston
Journal: AIDS Patient Care STDS Date: 2020-06-17 Impact factor: 5.078

2 in total